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ORIGINAL ARTICLE
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ABSTRACT
Pediatric diffuse lung diseases are rare disorders with an onset in the neonatal period or in infancy,
characterized by chronic respiratory symptoms and diffuse interstitial changes on imaging studies. Genetic
disorders of surfactant homeostasis represent the main etiology. Surfactant protein B and ABCA3 deficiencies
typically cause neonatal respiratory failure, which is often lethal within a few weeks or months. Although
heterozygous ABCA3 mutation carriers are mostly asymptomatic, there is growing evidence that monoallelic
mutations may affect surfactant homeostasis. Surfactant protein C mutations are dominant or sporadic
disorders leading to a broad spectrum of manifestations from neonatal respiratory distress syndrome to adult
pulmonary fibrosis. The authors performed pathology and ultrastructural studies in 12 infants who underwent
clinical lung biopsy. One carried a heterozygous SP-B mutation, 3 carried SP-C mutations, and 7 carried ABCA3
mutations (5 biallelic and 2 monoallelic). Optical microscopy made it possible to distinguish between
surfactant-related disorders and other forms. One of the ABCA3 monoallelic carriers had morphological
features of alveolar capillary dysplasia, a genetic disorder of lung alveolar, and vascular development. One
patient showed no surfactant-related anomalies but had pulmonary interstitial glycogenosis, a developmental
disorder of unknown origin. Electron microscopy revealed specific lamellar bodies anomalies in all SP-B, SP-C,
and ABCA3 deficiency cases. In addition, the authors showed that heterozygous ABCA3 mutation carriers have
an intermediate ultrastructural phenotype between homozygous carriers and normal subjects. Lung biopsy is
an essential diagnostic procedure in unexplained diffuse lung disorders, and electron microscopy should be
performed systematically, since it may reveal specific alterations in genetic disorders of surfactant homeostasis.
Keywords: ABCA3, alveolar capillary dysplasia, pediatric diffuse lung disease, SP-B, SP-C, surfactant
Pediatric diffuse lung diseases (pDLD) are a hetero-
geneous group of rare disorders characterized by
impaired gas exchange, diffuse infiltrates on imaging,
and an onset in infancy [1]. Genetic disorders of
surfactant synthesis and homeostasis represent an
important subset of these diseases, and are caused by
mutations in the genes encoding surfactant protein B
(SP-B), surfactant protein C (SP-C), ATP-binding
cassette transporter A3 (ABCA3), thyroid transcrip-
tion factor 1 (TTF-1), and others. SP-B and SP-C are
two hydrophobic proteins associated with surfactant
phospholipids and play a critical role in surfactant
tension active properties and homeostasis. Indeed,
mutations in these two genes are associated with
pDLD, while the other surfactant protein genes (SP-A
and SP-D), encoding for collectin-like molecules, have
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not been clearly associated with pDLD so far. SP-B
deficiency is caused by biallelic mutations with
autosomal recessive transmission, and is associated
with lethal respiratory distress syndrome (RDS) in
term neonates [2]. SP-C mutations are typically
monoallelic, 50% sporadic and 50% transmitted in
autosomal dominant mode, are associated with a
broad spectrum of clinical manifestations [3], includ-
ing neonatal RDS, interstitial lung disease (ILD) in
infants and children, familial pulmonary fibrosis in
adults, recurrent infections, and bronchiectasis [4],
and are also found in asymptomatic relatives of
carriers, indicating a variable penetrance likely influ-
enced by genetic and environmental factors. ABCA3
is a lipid transporter associated with lamellar bodies
and critical for surfactant synthesis. Complete ABCA3
deficiency caused by biallelic homozygous or double
heterozygous mutations typically leads to early-onset
RDS similar to SP-B deficiency [5], but has also been
associated with ILD in older children and adults,
similar to SP-C mutations [6,7]. Although heterozy-
gous carriers of ABCA3 mutations are considered as
asymptomatic, single ABCA3 mutations have been
described as disease modifiers, either isolated [8] or in
compound heterozygosity with mutations in other
surfactant genes [9]. TTF-1 is a nuclear factor that
plays an essential role both in early lung embryogen-
esis and in lung epithelium maturation and surfactant
synthesis, but also in thyroid and brain development
and function. TTF-1 is a critical regulator of the
expression of several other surfactant-related genes,
including SP-B, SP-C, and ABCA3 [10]. Mutations or
deletions causing haploinsufficiency of NKX2.1, the
gene that encodes TTF-1, lead to variable combin-
ations of respiratory failure, hypothyroidism and
brain-related symptoms, such as choreoathetosis and
hypopituitarism. Lung symptoms vary from early-
onset lethal RDS to recurrent respiratory failure and
ILD in older children and adults [11,12].
Another category of pDLDs of presumed genetic
origin is developmental lung disorders, including
alveolar capillary dysplasia with misalignment of
pulmonary veins (ACD), acinar dysplasia, and con-
genital alveolar dysplasia, a group of rare diseases of
alveolar and pulmonary vasculature development
manifesting as persistent pulmonary hypertension
and impaired gas exchange in full-term neonates
[13]. ACD is caused in 40% of cases by monoallelic
mutations and deletions of the FOXF1 gene and its
regulatory region [14].
Neuroendocrine cell hyperplasia of infancy (NEHI)
and pulmonary interstitial glycogenosis (PIG) repre-
sent other forms of pDLD in which a genetic origin is
suspected but not identified. PIG manifests as acute
progressive respiratory failure in newborn and infants,
but had a more favorable prognosis with respect to
other diffuse interstitial lung disease, and is amenable
to steroid therapy [15,16]. NEHI is characterized by
severe respiratory failure in newborn and infants not
correlated with significant histological changes and
usually reversible spontaneously [17].
Whereas optical histology provide limited insights
in the precise etiologic diagnosis of genetic surfactant
deficiencies, showing in most cases a nonspecific
patterns of desquamative interstitial pneumonia and/
or alveolar proteinosis, electron microscopy, even if an
often limited resource, represents the gold standard
instrument to identify such disorders, allowing
researchers to orient molecular and genetic studies
toward specific diagnoses and to differentiate them
from alternative causes of pDLD [18]. The object of this
article is to review the morphological and ultrastruc-
tural features of pDLD as observed in 12 infants and
children with pDLD referred for diagnosis to the
Bambino Gesu` Children Hospital, IRCCS, Rome,
Italy, a tertiary children’s hospital, who underwent
surgical lung biopsies and extensive molecular genetic
characterization.
PATIENTS AND METHODS
Patients
We screened a cohort of 88 patients recruited from
2007 to 2012 with pDLD. The infants’ ages ranged
from birth to 18 years, with a prevalence of neonates.
The inclusion criteria consisted of respiratory symp-
toms (abnormal auscultation, hypoxemia, cough,
increased work of breathing) and diffuse lung disease
on chest radiogram; children with an identified
etiology (bronchopulmonary dysplasia of prematur-
ity, lung hypoplasia, cystic fibrosis, lung bacterial,
viral and fungal infections, ciliary dyskinesia, airway
malformations, chronic aspiration, and structural
heart defect) were excluded. Eligible patients under-
went genetic testing and, with parental consent,
surgical lung biopsy. Blood samples for genetic
analysis were collected from the index patients and
each direct family member; lung biopsies or autopsy
specimens were obtained after informed parental
consent. Lung tissue samples from peripheral areas
of congenital cystic adenomatoid malformations
(CCAM) patients were used as normal control.
DNA Sequence Analysis
Screening for sequence variations in the SP-B, SP-C,
ABCA3, and TTF-1 encoding genes was performed by
direct sequencing of PCR-amplified products from
genomic DNA obtained from whole blood using the
QIAamp DNA blood minikit (Qiagen, Australia),
following the manufacturer’s instructions.
Polymerase chain reaction (PCR) amplifications were
performed on genomic DNA under standard
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conditions in a PTC 200 Peltier thermal cycler (MJ
Research, Watertown, MA, USA). Oligonucleotides
(purchased from Sigma) were derived from published
sequences [5]. The amplified fragments were purified
and directly sequenced on both strands using the CEQ
DTCS Quick Start Kit (Beckman Coulter). Sequencing
primers were the same as the ones used in amplifica-
tion reactions. Sequencing products were analyzed on a
CEQ200XL sequencer (Beckman Coulter). Parental
DNA was sequenced when samples were available,
and nonsynonymous mutations were analyzed in at
least 50 healthy subjects (100 chromosomes).
Microscopical Studies
For optical microscopy, 5-mm lung tissue sections from
formalin-fixed, paraffin-embedded samples obtained
by open chest wedge biopsy and/or autopsy were
stained with hematoxylin–eosin, periodic acid–Schiff
(PAS), and Weigert-Van Gieson staining for standard
histopathology. Ultrastructural studies were per-
formed using open chest lung biopsy fragments.
Samples were fixed in Karnowsky’s fixative, postfixed
in osmium tetroxide (OsO4), and dehydrated up to
absolute ethanol and embedded in EMbed-812.
Ultrathin sections were stained with lead citrate and
uranyl acetate and observed with a Zeiss EM
CENTRA 100 transmission electron microscope (Carl
Zeiss, Oberkochen, Germany) operated at 60 kV.
Control lung tissue was obtained from a term new-
born who underwent pulmonary lobectomy for con-
genital cystic adenoid malformation. In the subset
of patients with ABCA3 mutations (patients 5–11),
in order to obtain a semi-quantitative analysis of the
respective ultrastructural phenotype of biallelic and
monoallelic ABCA3 mutants, we determined the
average number per section and diameter of lamellar
bodies (LB) in 10 randomly selected sagittal sections
of alveolar epithelial type II cells (AEC2) for each case
and controls.
RESULTS
In 12 of the eligible patients, surgical lung biopsies
were performed and analyzed by optical (OM) and
electronic (EM) microscopy. Seven were males and 5
were females, with an age of 1–25 months. Patient 1
had respiratory failure at 1 month of age requiring
surfactant administration, and was discharged home
at 6 months on oxygen, steroids, and bronchodilators.
Patient 2 declared with hypoxemia at 1 month,
required mechanical ventilation from 3 months, and
died at 6 months; patients 3 and 4 became symptom-
atic at 6 months with persistent hypoxemia following
a bronchiolitis episode; patient 3 died at 19 months;
and patient 4 went home on oxygen and steroids at
13 months. Patients 5–9 were all term newborns
presenting with unexplained respiratory distress syn-
drome within the first week of life, requiring mech-
anical ventilation and multiple therapeutic surfactant
administration, and died between 3 and 9 months of
age. Patient 10 presented with severe RDS and
persistent pulmonary hypertension at birth but
could be discharged home on room air at 3 months,
then developed hypothyroidism and had recurrent
respiratory failure episodes. Patient 11 had persistent
hypoxemia since the first week of like, did not require
mechanical ventilation, but developed severe pul-
monary hypertension and died at 8 months. Patient 12
declared with hypoxemia and interstitial lung disease
at 3 months, and went home at 6 months on room air
after steroid treatment.
Genetic Findings
One patient (patient 1) carried a heterozygote muta-
tion (121ins2) of the SP-B gene. Three patients (2–4)
were heterozygous carriers of a SP-C mutation (E66K,
I73T, and V102M, respectively), Seven patients were
ABCA3 mutation carriers: 5 patients (5–9) carried
biallelic mutations (c3997delA in homozygosis and
the double heterozygous compounds R208W/T1423I,
R43L/R1482W, P147L/R155Q, and P248L/L941P,
respectively); 2 patients (10, 11) carried only a single
mutation (L941P and A501E). In the last patient (12)
no mutations were found.
Morphological Aspects
In patient 1 (monoallelic SP-B mutant), OM analysis
revealed abnormal accumulation of eosinophilic
granular material in the alveolar lumen positive to
periodic acid–Schiff staining, AEC2 hyperplasia, and
interalveolar septum thickening with fibroblast pro-
liferation (Figure 2A), a pattern initially described as
pulmonary alveolar proteinosis (PAP) in the literature,
although significantly different from the classic,
autoimmune PAP found in adults or the congenital
form caused by CSF2RA/B deficiency [19]. EM
analysis showed, both in the AEC2 cytoplasm and in
the proteinaceous exudate in alveolar lumen, clusters
of multivesicular bodies and/or composite bodies
(Figure 2B, C), in absence of the well-organized
concentric rings of phospholipid membrane normally
present in lamellar bodies (Figure 1B, C).
In patients 2–4 (monoallelic SP-C mutants), OM
features were characterized by scattered areas of
interalveolar septum thickening with inflammatory
infiltrates, fibroblast proliferation, and collagen
deposition, plus mixed amorphous and cellular con-
tent in alveolar spaces with some degree of AEC2
hyperplasia (Figure 3A), a pattern corresponding to
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nonspecific interstitial pneumonia (NSIP) and diffuse
interstitial pneumonia (DIP), found in different forms
of ILD in infants and children, and more age- than
disease-specific. Electron microscopy revealed mixed
appearance of LB, ranging from normal to enlarged
with no identifiable pseudomyelin layers and con-
taining electron-dense vesicles and disorganized
membranous aggregates (Figure 3B, C); in addition,
our patients showed large cytoplasmic vacuoles cor-
responding to early endosomes, and vesicular organ-
elles containing electron-dense material likely
corresponding to aggresomes (Figure 3D).
In patients 5–9 (biallelic ABCA3 mutants), OM
revealed diffuse AEC2 hyperplasia (Figure 4B), dif-
fuse cell and amorphous material accumulation in the
alveolar lumen, and interalveolar septum fibroblast
proliferation and fibrosis (Figure 4A), reported as DIP
or, improperly, PAP in the literature. One patient (7)
was characterized predominantly by alveolar, PAS-
positive lipoproteinaceous material accumulation
plus macrophages and desquamated epithelial cells
(data not shown), a pattern more similar to PAP.
Patients 10 and 11 (monoallelic ABCA3 mutants)
(Figure 4C) were not significantly distinct from those
patients with biallelic mutants (Figure 4D, E). EM
examination showed the presence of small, markedly
abnormal lamellar bodies with densely packed
phospholipid membranes or cristalline structures
and one or two electron-dense inclusions, designated
‘‘fried egg.’’ The number of these fried egg LB varied
according to the type of molecular defect, from
absent/rare in biallelic frameshift mutation to numer-
ous in certain biallelic missense mutations, whereas in
subjects with monoallelic mutations a mix of fried egg
and normal LB was observed. Biallelic mutants (n= 5)
have a smaller average LB number (p50.01) with a
smaller average diameter (p50.01) than controls
(n= 3); monoallelic mutants (n= 2) showed an average
LB number greater than biallelic carriers (p50.05)
similar to controls, but a smaller average diameter
than controls (p50.05), similar to biallelic carriers
(Figure 5).
In addition to her monoallelic ABCA3 mutation,
patient 11’s OM analysis revealed a marked reduc-
tion in pulmonary capillary density in the alveolar
septa failing to make contact with the alveolar basal
FIGURE 2. Lung tissue from heterozygous SP-B mutation carrier (patient 1). (A) Low-magnification OM showing alveolar spaces (*)
lined almost exclusively with type 2 epithelial cells (cuboid metaplasia) and filled with amorphous fluid and few cellular elements,
corresponding to a mixed picture of desquamative interstitial pneumonia and pulmonary alveolar proteinosis (HE, 20). (B) Medium-
magnifcation EM showing one type II epithelial cell with enlarged lamellar bodies containing destructured surfactant membranes and
no visible pseudomyelin (arrow), plus abundant multivesicular bodies (dashed arrow) and hypertrophic endoplasmic reticulum. (C)
High magnification of a lamellar body fusing with a multivesicular body.
FIGURE 1. Normal lung tissue from a 4-week-old infant with lung congenital cystic adenomatoid malformation. (A) Low-power
optical microscopy (OM) showing clear alveolar spaces lined with type I and type II epithelial cells, thin interalveolar septi.
Hematoxylin–eosin (HE), 20). (B) Low-magnification electron microscopy (EM) showing two type II alveolar cells facing contiguous
alveoli, with abundant lamellar bodies and pseudomyelin appearance of surfactant content (2000). (C) High magnification of normal
lamellar bodies, showing concentric phospholipid membranes (pseudomyelin) (10,000).
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membrane, plus increased muscularization of the
small arterioles and pulmonary veins adjacent to
the pulmonary arteries in the same adventitial
sheath (Figure 6A) and intraalveolar septi with
internalized capillary vessels (Figure 6B), a set of
features consistent with the diagnosis of ACD.
We retrospectively screened for FOXF1 point muta-
tions and microdeletions but did not find any
variations. A mixed ultrastructural phenotype
could be observed in this patient, including fried
egg inclusions in AEC2 typical of ABCA3 deficiency
(Figure 6C).
In patient 12, in whom no surfactant-related genetic
defect could be identified, OM analysis showed
enlarged interalveolar septa with PAS-positive
(Figure 7A) and diastase-sensitive material (not
shown) within the cytoplasm of mesenchymal cells,
indicating the presence of glycogen. At the ultra-
structural level, these interstitial cells had features
of primitive mesenchymal cells with vacuolized
cytoplasm (Figure 7B, C). Overall, these features are
typical of pulmonary interstitial glycogenosis (PIG).
DISCUSSION
Ultrastructural Aspects of the Normal Lung
Pulmonary surfactant is synthesized exclusively by
AEC2, which represent about 60% of alveolar epithelial
cells but appeared scattered and protruding among flat
type I cells, given their cuboid shape with a much
smaller basal surface. Mature AEC2 are characterized
by apical microvilli and LB, cell-specific organelles
clustered at the apical portion of the cytoplasm and
containing the intra-cellular surfactant pool appearing
as onion skin-like regular concentric lamellae, with a
pattern often designated pseudomyelin [20]. Around
birth, AEC2 are characterized by a higher LB and
mitochondrial number than in mature subjects,
FIGURE 3. Lung tissue from SP-C heterozygous carrier (patient 2). (A) Low-magnification OM showing alveolar spaces (*) with some
degree of cuboid metaplasia, to a lesser extent than in SP-B deficiency, mostly filled with amorphous fluid and abundant cellular
elements, and interstitial fibroblast proliferation and collagen deposition (þ), corresponding to desquamative interstitial pneumonia
(HE, 20). (B) Low-magnification EM showing an alveolar space (*) filled with heterogeneous material and a macrophage, and lined
predominantly with alveolar type II cells containing few abnormal lamellar bodies (arrows). (C) Medium-magnification EM of a type
II epithelial cell showing enlarged lamellar bodies containing disorganized lamellar structures (arrows) plus large endosomes (dashed
arrow) (6000). (D) High-power EM showing enlarged lamellar bodies with abnormal phospholipid content secreted in the alveolar
lumen (9000).
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whereas immature AEC2 show abundant cytoplasmic
glycogen pools and less numerous LB [21].
SP-B Deficiency
SP-B deficiency is an extremely rare autosomal reces-
sive disorder, with an estimated prevalence 51/106
live births, usually lethal in the first weeks of life,
whereas heterozygous carriers are asymptomatic. In
optical microscopy SP-B deficiency is characterized by
widened interstitium with fibroblast proliferation,
arrested acinar development with reduced alveolar
number, cuboid metaplasia of the alveolar epithelium,
and alveolar lumen filled with eosinophilic
FIGURE 4. Lung tissue from ABCA3 mutation carriers. (A) Low-magnification OM of a homozygous carrier (patient 5) showing
alveolar spaces (*) with near-total cuboid metaplasia, filled with amorphous fluid and abundant cellular elements, plus interstitial
fibroblast proliferation and collagen deposition (þ), corresponding to desquamative interstitial pneumonia (HE, 20). (B)
Immunohistochemistry staining with an anti-SP-B antibody, showing alveoli lined exclusively with type II cells and intraalveolar
surfactant protein accumulation and macrophages (IHC, 40). (C) High-magnification EM of a homozygous carrier (patient 5)
showing rarefied, small lamellar bodies (dashed arrows) with no visible pseudomyelin (9000). (D) High-magnification EM of a
biallelic double heterozygous carrier (#6) showing similar rarefied, small lamellar bodies (dashed arrows) with no visible
pseudomyelin (9000). (E) Low-magnification EM of a monoallelic, heterozygous carrier (patient 10) showing a mix of normal-
appearing lamellar bodies (arrows) and small amorphous lamellar bodies (dashed arrow) in a neighboring cell. (F) High-power EM
of a cluster of lamellar bodies in a homozygous carrier (patient 5) with densely packed membranes and denser cores, designated
‘‘fried eggs’’.
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proteinaceous material containing macrophages and
desquamated clusters of epithelial cells, a pattern
described as DIP, although it was often reported as
PAP in the former literature [22]. LB morphology and
the ultrastructural features of intracellular surfactant
are very distinctive: normal, mature LB with well-
organized pseudomyelin structures are not present,
and are replaced by larger cytoplasmic inclusion with
irregularly disposed lamellae and multiple associated
membranous and vesicular structures [23].
FIGURE 5. Comparision of lamellar body density and size in biallelic and monoallelic ABCA3 mutation carriers. (A) Average lamellar
body number per cell saggital section (10 sections/case) in biallelic carriers (n= 5), monoallelic carriers (n= 2), and controls (n= 3).
*p50.05; **p50.01. (B) Average lamellar body diameter (nm) in biallelic carriers (n= 5 10 sections), monoallelic carriers (n= 2), and
controls (n= 3). *p50.05; **p50.01.
FIGURE 6. Lung tissue from patient with alveolar capillary dysplasia and heterozygous ABCA3 mutation carrier (patient 11). (A)
High-magnification OM showing a pulmonary arteriole (art) with thickened media, with two pulmonary venules (v) running parallel
to the artery in the same adventitial sheath. Weigert-Van Gieson staining, 40. (B) Immunohistochemistry staining with anti-CD31
antibody, showing decreased density of pulmonary capillaries that fail to make contact with the alveolar basal membrane (40). (C)
Medium-power EM showing a mix of normal (arrow) and fried egg lamellar bodies (dashed arrow).
FIGURE 7. Pulmonary interstitial glycogenosis (patient 12). (A) OM showing enlarged interalveolar septa with PAS-positive material
within the cytoplasm of mesenchymal cells, corresponding to glycogen. (B) Medium-power EM showing intracellular glycogen
deposits (6000). (C) Monoparticulate glycogen deposits (12,000).
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These findings are compatible with animal studies,
where SP-B-deficient mice are characterized by high
neonatal mortality, a complete absence of LB, and the
presence of inclusions containing numerous small
vesicles and electron-dense masses in AEC2 [24].
Although our case is a heterozygote carrier of the
121ins2 mutation and the clinical phenotype was
milder than that typically reported for homozygous
carriers, ultrastructural features were typical of SP-B
deficiency and suggest the presence of an unidentified
mutation in the second allele [25].
SP-C Deficiency
SP-C deficiency is clinically the most heterogeneous
defect of surfactant homeostasis. Mutations in SP-C
range from fatal pulmonary surfactant deficiency to
pediatric interstial lung disease and to adult familial/
idiopathic pulmonary fibrosis, with asymptomatic
carriers being described in affected families. Most
SP-C mutations cluster in the noncoding C-terminal
part of the proSP-C apoprotein and lead to misfolding
protein cell response, amyloid formation, and epithe-
lial cell apoptosis (BRICHOS mutations) or to mis-
trafficking to the endosomal compartment and
intraalveolar abnormal apoprotein products accumu-
lation (non-BRICHOS mutations) [26]. Lung morph-
ology in SP-C deficiency is characterized by diffuse
alveolar damage, interstitial thickening with fibroblast
proliferation and collagen deposition, abundant
foamy alveolar macrophages and granular lipoproteic
material in the alveolar lumen, and AEC2 hyperpla-
sia, corresponding to DIP, albeit with a more scattered,
multifocal pattern, multiple fibrosis foci and an
overall broader variability between subjects that in
SP-B deficiency [27]. Surprisingly, in the complete SP-
C deficiency mouse model, the number of AEC2 was
similar compared to wild type and well-organized
lamellar bodies were detected. However, lung mech-
anics studies showed a lower lung compliance at the
end-expiratory pressure and increased sensitivity to
lung injury, suggesting that SP-C stabilizes the
phospholipid film at reduced lung volumes [28].
ABCA3 Deficiency
In our cohort, as in several other published series
[5,29,30], ABCA3 deficiency was the most common
defect. Infants with ABCA3 mutations have a spec-
trum of clinical presentation and lung morphology
alterations similar to those with either SP-B or SP-C
mutations, but ultrastructural examination of AEC2
demonstrates distinctive features, consisting of abnor-
mal LB with tightly packed concentric membranes
and an aggregate of electron-dense material (fried egg
appearance) [23]. ABCA3-deleted mice have a similar
phenotype to humans, with fried egg and low number
LB [31], and resulted in respiratory failure after birth.
ABCA3 is located in LB membranes and involved in
intracellular lipid transport and intracellular surfac-
tant packaging. Although ABCA3 deficiency is typic-
ally described as an autosomal recessive disorder with
healthy heterozygous carriers, some recent data sug-
gest that monoallelic mutations affect surfactant
homeostasis and may cause or alter the course of
lung disease in infants [7]. The mixed ultrastructural
phenotype we observed in two single mutation
carriers, consisting of LB numbers similar to controls
but diameters similar to biallelic (homozygous or
double heterozygous) mutants, suggests that partial
ABCA3 deficiency affects surfactant homeostasis and
therefore can be at least partially responsible for the
clinical phenotype.
Alveolar Capillary Dysplasia (ACD)
ACD is a rare disorder of early lung development of
unknown pathogenesis, leading to defective angio-
genesis and alveolar development, the molecular
mechanisms of which are still largely unknown.
Genetically, ACD is a heterogeneous disease, since
FOXF1 variants could not be demonstrated in more
than half the published cases. Histologically, it is
characterized by a scattered pattern of interalveolar
septal thickening, decreased terminal bronchial ram-
ification and alveolar number, increased musculariza-
tion in small pulmonary arteries, misalignment of
pulmonary veins along small pulmonary arteries, and
decreased capillary number failing to make an appro-
priate contact with the alveolar basal membrane,
leading to pulmonary hypertension and impaired gas
exchange [32]. In more than 50% cases ACD is
associated with malformations in other organs invol-
ving the gastrointestinal, cardiovascular, and geni-
tourinary systems, suggesting a more pervasive
embryonic process [33]. ACD is best diagnosed by
optical microscopy, showing the specific morpho-
logical features described above; reduced capillary
density can be further evidenced by immunohisto-
chemestry techniques using endothelial marker
antibodies, such as CD31 or VFGE. EM can be
used to demonstrate capillary internalization,
but is also important for differential diagnosis,
showing the integrity of the surfactant system or,
as in our case, the presence of an associated surfac-
tant gene defect [34].
Pulmonary Interstitial Glycogenosis (PIG)
PIG is an extremely rare and possibly underrecog-
nized disease of unknown etiology, which causes
respiratory failure in newborns and can be associated
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with congenital heart disease and persistent pulmon-
ary hypertension. Although its histological hallmark
consists of thickened interstitium with immature
interstitial cells containing intracytoplasmic glycogen,
PIG is not linked to deficiency of enzymes related to
glycogen metabolism, but is believed to correspond to
a maturation deficiency of the interstitial fibroblasts.
Ultrastructural studies show primitive intestitial cells
with few organelles and abundant monoparticulate
glycogen, whereas no abnormal glycogen accumula-
tion can be seen in AEC2. PIG has been shown to
respond clinically to corticosteroid therapy, suggest-
ing that this defect can be reversed by inducing and
accelerating interstitial cell maturation [35]. No gen-
etic etiology has been identified so far. Some authors
consider PIG to be a disorder of alveolar growth, since
it can also be observed as a focal lesion adjacent to
masses or cystic lesions, or in exacerbation phases of
chronic lung disease of prematurity [36].
CONCLUSION
The clinical and anatomopathological overlap of
congenital diffuse lung disorders makes ultrastruc-
tural examination essential for establishing the diag-
nosis of surfactant homeostasis disorder in patients
with suggestive, unexplained phenotypes. Moreover,
AEC2 ultrastructural analysis may allow identifica-
tion of or suggest the genetic defect underlying the
disease and permit faster and more specific molecular
testing. Hence, surgical lung biopsy should be rec-
ommended in infants and children with unexplained
pDLD, and should always include proper samples for
ultrastructural analysis.
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